We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
For investors seeking momentum, iShares Core S&P Total U.S. Stock Market ETF (ITOT - Free Report) is probably on radar. The fund just hit a 52-week high and is up roughly 56.6% from its 52-week low price of $48.52/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
ITOT in Focus
ITOT provides exposure to the total U.S. stock market, ranging from some of the smallest to the largest companies. It has key holdings in information technology, healthcare and consumer discretionary. The product charges 3 basis points in fees (see: all the Cap Blend ETFs here).
Why the Move?
The U.S. stock market has been an area to watch lately given that the S&P 500 hit a new record high. The sharp rebound from the trough seen in March to a new peak represents 126 trading days and the fastest-ever recovery from a bear market in the history of the index. The combination of unprecedented fiscal and monetary stimulus in response to the pandemic, hopes of a swift economic rebound and high chances of a successful coronavirus vaccine drove the stocks higher.
More Gains Ahead?
Currently, ITOT has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook, suggesting continued outperformance in the months ahead. Further, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Broad Market ETF (ITOT) Hits New 52-Week High
For investors seeking momentum, iShares Core S&P Total U.S. Stock Market ETF (ITOT - Free Report) is probably on radar. The fund just hit a 52-week high and is up roughly 56.6% from its 52-week low price of $48.52/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
ITOT in Focus
ITOT provides exposure to the total U.S. stock market, ranging from some of the smallest to the largest companies. It has key holdings in information technology, healthcare and consumer discretionary. The product charges 3 basis points in fees (see: all the Cap Blend ETFs here).
Why the Move?
The U.S. stock market has been an area to watch lately given that the S&P 500 hit a new record high. The sharp rebound from the trough seen in March to a new peak represents 126 trading days and the fastest-ever recovery from a bear market in the history of the index. The combination of unprecedented fiscal and monetary stimulus in response to the pandemic, hopes of a swift economic rebound and high chances of a successful coronavirus vaccine drove the stocks higher.
More Gains Ahead?
Currently, ITOT has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook, suggesting continued outperformance in the months ahead. Further, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>